LOCALIZATION OF FIBRIL MICROFIBRIL AND BASEMENT-MEMBRANE COLLAGENS IN DIABETIC GLOMERULOSCLEROSIS IN TYPE-2 DIABETES

被引:29
作者
MAKINO, H
SHIKATA, K
WIESLANDER, J
WADA, J
KASHIHARA, N
YOSHIOKA, K
OTA, Z
机构
[1] Third Department of Internal Medicine, Okayama University Medical School, Okayama
[2] Statens Seruminstitut, Copenhagen
[3] Department of Pediatrics, Kinki University School of Medicine, Osaka
关键词
DIABETIC NEPHROPATHY; TYPE-IV COLLAGEN; TYPE-VI COLLAGEN; TYPE-III COLLAGEN; COLLAGEN CHAIN;
D O I
10.1111/j.1464-5491.1994.tb00276.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Collagen is one of the major components of the extracellular matrices of the kidney. Basement membrane collagen, type IV collagen, is the major component in normal glomeruli. Fibril and interstitial collagen such as type III collagen, type V collagen, and type VI collagen are minor components of glomerular extracellular matrices and are localized mainly in the interstitium. Diabetic glomerulosclerosis is characterized by the expansion of the glomerular mesangial matrix as well as by thickening of the glomerular basement membrane. In order to clarify the roles of these various types of collagen in the development of diabetic glomerulosclerosis, immunohistochemical studies were perfomed in kidney specimens from patients with Type 2 diabetes. Early glomerulosclerosis is characterized by expansion of mesangial matrix with basement membrane collagen. However, in later stages glomerulosclerosis is characterized by an increase in the minor collagen components, such as type V and type VI collagen or collagens not normally present, such as type III collagen. Mesangial cells are known to synthesize all these types of collagen. In diabetes, phenotypic change in mesangial cells might produce excess amounts of fibril and interstitial collagen such as type III, type V, and type VI collagen, thus, leading to glomerulosclerosis.
引用
收藏
页码:304 / 311
页数:8
相关论文
共 29 条
[1]  
Gellman DD, Pirani CL, Soothill JF, Muehrecke RC, Kark RM., Diabetic nephropathy. A clinical and pathologic study based on renal biopsies, Medicine, 38, pp. 321-367, (1959)
[2]  
Kanwar YS., Biology of disease. Biophysiology of glomerular filtration and proteinuria, Lab Invest, 51, pp. 7-21, (1984)
[3]  
Ramirez F., Organization and evolution of the fibrillar collagen genes, Collagen, vol. IV, Molecular Biology, pp. 21-30, (1989)
[4]  
Makino H., Yamasaki Y., Haramoto T., Shikata K., Hironaka K., Ota Z., Et al., Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy, Lab Invest, 68, pp. 45-55, (1993)
[5]  
Timpl R., Aumailly M., Biochemistry of basement membranes, Advances in Nephrology, 18, pp. 59-76, (1989)
[6]  
Hudson BG, Wieslander J., Wisdom BJ, Noelken ME., Biology of disease. Goodpasture syndrome. Molecular architecture and function of the basement membrane antigen, Lab Invest, 61, pp. 256-269, (1989)
[7]  
Butkowski RJ, Langeveld JPM, Wieslander J., Hamilton J., Hudson BG., Localization of the Goodpasture epitope to a novel chain of basement membrane collagen, J Biol Chem, 262, pp. 7874-7877, (1987)
[8]  
Butkowski RJ, Shen G., Weislander J., Michael AF, Fish AJ., Characterization of type IV collagen NC1 monomers and Goodpasture antigen in human renal basement membranes, J Lab Clin Med, 115, pp. 365-373, (1990)
[9]  
Saus J., Wieslander J., Langeveld JPM, Quinsones S., Hudson BG., Identification of Goodpasture antigen as the α3(IV) chain of collagen IV, J Biol Chem, 263, pp. 13374-13380, (1988)
[10]  
Kim Y., Kleppel MM, Butkowski R., Mauer SM., Differential expression of basement membrane collagen chains in diabetic nephropathy, Am J Pathol, 138, pp. 413-420, (1991)